AI assistant
Sending…
Passage BIO, Inc. — Director's Dealing 2022
Oct 12, 2022
34849_dirs_2022-10-12_940ab5f8-553a-482b-b709-983caff8fe4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2022-10-10
Reporting Person: Chou William (Director, Chief Executive Officer)
More from Passage BIO, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Director's Dealing
2026
Mar 18
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3